Boston Scientific's Suppliers recorded an increase in sales by 5.81 % year on year in Q2 2026, sequentially sales grew by 15.42 %, Boston Scientific's cost of sales deteriorated by -2.63 % year on year, sequentially cost of sales grew by 0.25 % in Q2.
Boston Scientific's Suppliers recorded an increase in sales by 5.81 % year on year in Q2 2026, sequentially sales grew by 15.42 %, Boston Scientific's cost of sales deteriorated by -2.63 % year on year, sequentially cost of sales grew by 0.25 % in Q2.
The company focuses on enhancing supply chain effectiveness, manufacturing processes, and operational efficiencies on a global scale. It develops and launches new products, improves existing products, and drives continuous product quality improvements through process controls, validations, and supplier and distribution controls. The company operates a supplier resiliency program to identify and mitigate risks and implements measures to address global supply chain challenges. It consistently monitors inventory levels, manufacturing, sterilization, distribution capabilities, and partnerships, maintaining recovery plans for potential disruptions or material shortages. While many components are fabricated from commonly available raw materials or off-the-shelf items sourced from multiple suppliers, some components are custom-made or obtained from single suppliers due to quality, expertise, cost, or regulatory requirements. Although the supply of certain raw materials and components has been stable, risks remain that could result in increased costs or an inability to meet customer demand.
Boston Scientific's Comment on Supply Chain
The company focuses on enhancing supply chain effectiveness, manufacturing processes, and operational efficiencies on a global scale. It develops and launches new products, improves existing products, and drives continuous product quality improvements through process controls, validations, and supplier and distribution controls. The company operates a supplier resiliency program to identify and mitigate risks and implements measures to address global supply chain challenges. It consistently monitors inventory levels, manufacturing, sterilization, distribution capabilities, and partnerships, maintaining recovery plans for potential disruptions or material shortages. While many components are fabricated from commonly available raw materials or off-the-shelf items sourced from multiple suppliers, some components are custom-made or obtained from single suppliers due to quality, expertise, cost, or regulatory requirements. Although the supply of certain raw materials and components has been stable, risks remain that could result in increased costs or an inability to meet customer demand.
BSX's Suppliers Net Income grew by
BSX's Suppliers Net margin grew in Q2 to
158.06 %
21.23 %
BSX's Suppliers Net Income grew by 158.06 %
BSX's Suppliers Net margin grew in Q2 to 21.23 %
Boston Scientific's Suppliers Sales Growth
in Q2 2026 by Industry
Sources:
Boston Scientific Corporation's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Boston Scientific Corporation’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
5 % 